Using Wharton's Jelly MSC
23Century utilizes Wharton's Jelly MSC (WJ-MSC), which possesses high regenerative capabilities.
Wharton's Jelly MSC are derived from the umbilical cord (umbilicus) of newborn babies and are mesenchymal stem cells that possess high proliferative capacity and can differentiate into various cell types.
Therefore, this cell is effective for the repair of damaged tissue and immune modulation, making it widely utilized in the field of regenerative medicine.
In addition, this cell also secretes large quantities of growth factors and anti-inflammatory substances, helping to reduce inflammation and stimulate tissue regeneration.
This makes it relevant for applications in neurological disorders, autoimmune diseases, joint diseases, and others.
Internationally Certified Independent Culture Facility
The 23 Century International Life Science Centre (23C) is an international stem cell research institution based in Kuala Lumpur, equipped with the largest cell culture and manufacturing facilities in Southeast Asia.
Recognized by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia and complying with cGTPs and cGMP requirements in accordance with PIC/S standards, we provide high-quality cell products.
More than 20,000 Clinical Records
To ensure the effectiveness and safety of Stem Cell Therapy, many years of accumulated research and clinical data are required.
23C has conducted over 20,000 clinical trials in Stem Cell Therapy, contributing to the advancement of therapeutic techniques in collaboration with medical institutions worldwide.
We also provide technology to over 70 countries, aiming to expand the application scope and standardization of Stem Cell Therapy.
International Standard Quality Assurance System
Stem cell quality is paramount to the success and safety of therapy, necessitating stringent quality control.
23C implements production processes compliant with cGMP and cGTPs, featuring Grade A & B cleanrooms for the stringent control of high-quality cell culture and production.
We have successfully passed the NPRA Malaysia audit and comply with PIC/S standards, ensuring quality assurance to international standards.
Stringent Risk and Security Management
To ensure the safety of Stem Cell Therapy, we ensure traceability for each cell and implement a 24-hour monitoring system.
To ensure quality, the final product is only released following stringent quality control testing, including contaminant testing, viral screening, and viability assessment.
Furthermore, we conduct risk assessments in accordance with PIC/S standards to provide safe Stem Cell Therapy.
Full Support by Specialized Staff
We also play a vital role in alleviating concerns such as language barriers and cultural or systemic differences when undergoing advanced medical treatment abroad.
We provide support by Japanese-speaking staff.
Our staff provides comprehensive support, covering everything from Japanese language communication during consultations and travel scheduling to on-site assistance.
On the day of your treatment, we will accompany you to our dedicated lounge to ensure a tranquil waiting experience. Throughout your treatment journey, we are here to offer reassurance and support.
We continue to innovate at the forefront of Stem Cell Therapy and provide evidence-based medical treatments.
We place the health and future of patients as a priority, and strive to provide the most suitable treatment recommendations for each individual.
If you are considering Stem Cell Therapy, we encourage you to consult with us. We provide a supportive environment, ensuring you can receive treatment with peace of mind.